Reference : 1. Abdu Dahab A and Al-Salih, A. An overview of cervical abnormalities at the maternity and childre
more
Reference : 1. Abdu Dahab A and Al-Salih, A. An overview of cervical abnormalities at the maternity and children‘s hospital (Jeddah) over one year. Saudi journal of Obstetric and Gynecology 2002; 2: 143-148. 2. Abduljabbar HS. Abnormal cervical cytology, a preliminary report from western region of Saudi Arabia. Saudi Med J 1990; 11:372-375. 3. Altaf F. Cervical cancer screening with pattern of Pap smear: Review of multicenter studies. Saudi Med J 2006; Vol. 27 (10): 1498-1502. 4. Altaf F. Pattern of cervical smear cytology in the western region of Saudi Arabia. Annals of Saudi Medicine 2001; 21: 94-96. 5. Mansoor I. Profile of Cervical Smears Cytology in Western Region of Saudi Arabia. The Internet Journal of Pathology 2002; Volume 2, Number 1. 6. Jamal A, Al-Maghrabi J. Profile of Pap smear cytology in the western region of Saudi Arabia. Saudi Med J 2003; Vol.24 (11): 1225-1229. 7. Howaida A-E, Al-Ghamdi A-H and Al-Maghrabi J. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi Med J 2005; Vol.26 (4): 588-592. 8. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol 1999; 189:12-19. 9. Kulmala SM, S. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004; 42(6):2470-2475. 10. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52(6):342-362. 11. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932n women. British Journal of Cancer 2001; 84: 1616-1623. 12. Goodman A and Hutchinson ML. Cell surplus on sampling devices after routine cervical cytologic smears. A study of residual cell populations. J. Reprod Med 1996; 41 (4): 239-241. 13. Marion, D; Holmquist, CT; Keebler, CM and CFIAC, ScD. In: The Manual of cytotechnology. Keebler, CM and Somrak, TM. American Society of Clinical Pathologists. Publisher: Chicago: ASCP Press. Somrak, TM (Editor). Cytopreparatory Techniques 1993; 35:.412-448. 14. Clavel C, Masure M, Putaud I, Thomas K, and Bory JP et al. Hybrid Capture II, a new sensitive test for human papillomavirus detection: comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol 1998; 51:737-740. 15. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley J E, Fetterman B J, Hartinger JS, McIntosh KM, Pawlick GF and Hiatt RA. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. Obstetrical & Gynaecological Survey 1999 September; 54(9):569-571. 16. Wright TC Jr, Cox JT, Massad LS, Twiggs LB and Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-2129. 17. Raffle AE, Alden, B; Quinn, M; Babb, P J and Brett, M T. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003 Apr 26; 326(7395):901-904. 18. Dominguez GM, Ortiz de Lejarazu R, Curiel A, Eiros JM, Moreno M, Labayru C, Ortega M, Hern?ndez B, Reguera JI and Rodriguez-Torres A. HPV diagnosis in the clinical setting. Correlation and discrepancies between molecular techniques. Rev Electron Biomed / Electron J Biomed 2005; 1:91-93. 19. Karisen F, Kristensen G, Holm R, Chitemerere M, Berner A and Hagmar BM. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions. Eur J Cancer 1995; 31A: 1511-1516. 20. Schiecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL and Franco EL. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 2003; 103:519-524. 21. Syrjänen K and Syrjänen S (2000). Papillomavirus infections in human pathology. John Wiley & Sons, Inc., New York, N.Y. 22. Mao C, KoutskyL A, Ault KA, Wheeler CM, Brown DR and Wiley DJ. Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia. Obstetrics and Gynaecology 2006; 107:18-27. 23. Molijn A, Kleter B, Quint W and van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32S:S43-S51. 24. Daniel RW, Ahdieh L, Hayden D, Cu-Uvin S and Shah KV. Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J Clin Virol 2000; 19:187-193.
less